CLVR vs TMO · rev $17.4M vs P/E 24, rev $44.56B
Clever Leaves Holdings Inc (CLVR) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Clever Leaves Holdings Inc (CLVR) is a drug manufacturers - specialty & generic company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CLVR revenue for 2023-12-31 was $17.4M. Net income was -$17.9M. Revenue was up 6.1% from 2022-12-31 to 2023-12-31. CLVR currently screens at market cap $1.4K.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CLVR currently screens at market cap $1.4K. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CLVR and TMO stock pages for the full models.
Not investment advice.